Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT02669758
Eligibility Criteria:
Inclusion Criteria:
* Subject has completed the 4-week treatment period (all visits up to and including end of treatment visit) in the antecedent study ALK3831-A305 within 7 days.
* Agrees to use an acceptable method of contraception for the duration of the study.
* Additional criteria may apply.
Exclusion Criteria:
* Subject is currently taking medications that are contraindicated with olanzapine use.
* Subject has a positive test for drugs of abuse at study entry.
* Subject is pregnant, planning to become pregnant, or breastfeeding during the study.
* Additional criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02669758
Study Brief:
Protocol Section:
NCT02669758